Romano Danesi (R Danesi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Venues

Cancers

Pharmacogenomics

JCO precision oncology

The pharmacogenomics journal

Scuola Superiore Sant'Anna (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Scuola Superiore Sant'Anna Nov 01 1983 - Apr 15 1988

Italy

PHD

Publications

Sara Mucherino, Valentina Lorenzoni, Isotta Triulzi, Marzia Del Re, Valentina Orlando, Annalisa Capuano, Romano Danesi, Giuseppe Turchetti, Enrica Menditto
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review. Cancers 16 (5) (2024)
Matti Aapro, Stefano Fogli, Bart J Morlion, Romano Danesi
Opioid metabolism and drug-drug interaction in cancer. The oncologist (2024)
Sara Mucherino, Valentina Lorenzoni, Isotta Triulzi, Marzia Del Re, Valentina Orlando, Annalisa Capuano, Romano Danesi, Giuseppe Turchetti, Enrica Menditto
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review. Cancers 16 (5) (2024)
Stefania Crucitta, Martina Ruglioni, Giulia Lorenzini, Irene Bargagna, Giovanna Irene Luculli, Irene Albanese, Diana Bilancio, Francesca Patanè, Andrea Fontana, Romano Danesi, Marzia Del Re
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients. Cancers 15 (4) (2023)
Valerio Renzelli, Marco Gallo, Lelio Morviducci, Giampiero Marino, Alberto Ragni, Enzo Tuveri, Antongiulio Faggiano, Rossella Mazzilli, Annalisa Natalicchio, Maria Chiara Zatelli, Monica Montagnani, Stefano Fogli, Dario Giuffrida, Antonella Argentiero, Romano Danesi, Stella D'Oronzo, Stefania Gori, Tindara Franchina, Antonio Russo, Matteo Monami, Laura Sciacca, Saverio Cinieri, Annamaria Colao, Angelo Avogaro, Graziano Di Cianni, Francesco Giorgino, Nicola Silvestris
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer. Cancers 15 (17) (2023)
Stefania Crucitta, Martina Ruglioni, Giulia Lorenzini, Irene Bargagna, Giovanna Irene Luculli, Irene Albanese, Diana Bilancio, Francesca Patanè, Andrea Fontana, Romano Danesi, Marzia Del Re
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients. Cancers 15 (4) (2023)
Giorgio Guglielmi, Stefania Crucitta, Lorenzo Bertani, Martina Ruglioni, Giovanni Baiano Svizzero, Linda Ceccarelli, Marzia Del Re, Romano Danesi, Francesco Costa, Stefano Fogli
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics. Inflammatory bowel diseases (2023)
Stefania Crucitta, Martina Ruglioni, Giulia Lorenzini, Irene Bargagna, Giovanna Irene Luculli, Irene Albanese, Diana Bilancio, Francesca Patanè, Andrea Fontana, Romano Danesi, Marzia Del Re
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients. Cancers 15 (4) (2023)
Marzia Del Re, Stefania Crucitta, Federico Paolieri, Federico Cucchiara, Elena Verzoni, Francesco Bloise, Raffaele Ciampi, Chiara Mercinelli, Annalisa Capuano, Liberata Sportiello, Antonia Martinetti, Giuseppe Procopio, Luca Galli, Camillo Porta, Sergio Bracarda, Romano Danesi
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs. Journal of translational medicine 20 (1) (2022)
Federico Cucchiara, Rosa Scarpitta, Stefania Crucitta, Cristian Scatena, Roberta Arici, Antonio Giuseppe Naccarato, Stefano Fogli, Romano Danesi, Marzia Del Re
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management. Pharmacogenomics 23 (2) (2022)
Francesco Pantano, Francesca Zalfa, Michele Iuliani, Sonia Simonetti, Francesco Pantano, Andrea Napolitano, Simone Tiberi, Marco Russano, Fabrizio Citarella, Simone Foderaro, Elisabetta Vulpis, Alessandra Zingoni, Laura Masuelli, Roberto Bei, Giulia Ribelli, Marzia Del Re, Romano Danesi, Bruno Vincenzi, Giuseppe Perrone, Giuseppe Tonini, Daniele Santini
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients. Cancers 14 (10) (2022)
Federica Marmorino, Michele Prisciandaro, Mirella Giordano, Elisa Ortolan, Stefania Crucitta, Francesco Pantano, Carlotta Antoniotti, Marta Maria Valenti, Romano Danesi, Veronica Conca, Giacomo Mazzoli, Alessandra Boccaccino, Martina Carullo, Antonia Martinetti, Elisa Sottotetti, Gianluca Masi, Carlo Sposito, Nadia Zaffaroni, Massimo Milione, Gabriella Fontanini, Marzia Del Re, Filippo Pietrantonio, Chiara Cremolini
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases. JCO precision oncology 6 (2022)
Gabriele Moretti, Paolo Aretini, Francesca Lessi, Chiara Maria Mazzanti, Guntulu Ak, Muzaffer Metintaş, Cecilia Lando, Rosa Angela Filiberti, Marco Lucchi, Alessandra Bonotti, Rudy Foddis, Alfonso Cristaudo, Andrea Bottari, Alessandro Apollo, Marzia Del Re, Romano Danesi, Luciano Mutti, Federica Gemignani, Stefano Landi
Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study. Cancers 13 (10) (2021)
Marzia Del Re, Caterina Vivaldi, Eleonora Rofi, Francesca Salani, Stefania Crucitta, Silvia Catanese, Lorenzo Fontanelli, Valentina Massa, Federico Cucchiara, Lorenzo Fornaro, Annalisa Capuano, Stefano Fogli, Enrico Vasile, Romano Danesi
Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer. Cancers 13 (15) (2021)
Tessa A M Mulder, Mirjam de With, Marzia Del Re, Romano Danesi, Ron H J Mathijssen, Ron H N van Schaik
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy. Cancers 13 (4) (2021)
Caterina Vivaldi, Stefania Crucitta, Silvia Catanese, Federico Cucchiara, Elena Arrigoni, Irene Pecora, Eleonora Rofi, Lorenzo Fornaro, Francesca Salani, Valentina Massa, Enrico Vasile, Riccardo Morganti, Romano Danesi, Marzia Del Re
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 21 (2) (2021)
Giorgia Maroni, Mahmoud Adel Bassal, Indira Krishnan, Chee Wai Fhu, Virginia Savova, Rapolas Zilionis, Valerie A Maymi, Nicole Pandell, Eva Csizmadia, Junyan Zhang, Barbara Storti, Julio Castaño, Riccardo Panella, Jia Li, Corinne E Gustafson, Sam Fox, Rachel D Levy, Claire V Meyerovitz, Peter J Tramontozzi, Kimberly Vermilya, Assunta De Rienzo, Stefania Crucitta, Daniela S Bassères, Marla Weetall, Art Branstrom, Alessandra Giorgetti, Raffaele Ciampi, Marzia Del Re, Romano Danesi, Ranieri Bizzarri, Henry Yang, Olivier Kocher, Allon M Klein, Robert S Welner, Raphael Bueno, Maria Cristina Magli, John Gerard Clohessy, Azhar Ali, Daniel Geoffrey Tenen, Elena Levantini
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer. Communications biology 4 (1) (2021)
Marzia Del Re, Federico Cucchiara, Iacopo Petrini, Stefano Fogli, Antonio Passaro, Stefania Crucitta, Ilaria Attili, Filippo De Marinis, Antonio Chella, Romano Danesi
erbB in NSCLC as a molecular target: current evidences and future directions. ESMO open 5 (4) (2021)
M Del Re, Vincenza Conteduca, S Crucitta, G Gurioli, Chiara Casadei, G Restante, G Schepisi, C Lolli, Federico Cucchiara, Romano Danesi, U De Giorgi
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide. Prostate cancer and prostatic diseases 24 (2) (2021)
Marco Falcone, Giusy Tiseo, Greta Barbieri, Valentina Galfo, Alessandro Russo, Agostino Virdis, Francesco Forfori, Francesco Corradi, Fabio Guarracino, Laura Carrozzi, Alessandro Celi, Massimo Santini, Fabio Monzani, Salvatore De Marco, Mauro Pistello, Romano Danesi, Lorenzo Ghiadoni, Alessio Farcomeni, Francesco Menichetti, null null
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study. Open forum infectious diseases 7 (12) (2020)
Marzia Del Re, Federico Cucchiara, Eleonora Rofi, Lorenzo Fontanelli, Iacopo Petrini, Nicole Gri, Giulia Pasquini, Mimma Rizzo, Michela Gabelloni, Lorenzo Belluomini, Stefania Crucitta, Raffaele Ciampi, Antonio Frassoldati, Emanuele Neri, Camillo Porta, Romano Danesi
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC. Cancer immunology, immunotherapy : CII 70 (6) (2020)
Marzia Del Re, Alfredo Addeo, Antonio Passaro, Iacopo Petrini, Ron Hn van Schaik, Romano Danesi
Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment. Pharmacogenomics 20 (18) (2020)
Marzia Del Re, Giulia Gianfilippo, Stefania Crucitta, Alfredo Addeo, Ron Hn van Schaik, Romano Danesi
Circulating biomarkers of response to immunotherapy in cancer treatment. Pharmacogenomics 20 (18) (2019)
Marzia Del Re, Eleonora Rofi, Carla Cappelli, Gianfranco Puppo, Stefania Crucitta, Simona Valeggi, Antonio Chella, Romano Danesi, Iacopo Petrini
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report. BMC cancer 19 (1) (2019)
Marzia Del Re, Ilaria Bertolini, Stefania Crucitta, Lorenzo Fontanelli, Eleonora Rofi, Claudia De Angelis, Lucrezia Diodati, Diletta Cavallero, Giulia Gianfilippo, Barbara Salvadori, Stefano Fogli, Alfredo Falcone, Cristian Scatena, Antonio Giuseppe Naccarato, Manuela Roncella, Matteo Ghilli, Riccardo Morganti, Andrea Fontana, Romano Danesi
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients. Breast cancer research and treatment 178 (1) (2019)
Marzia Del Re, Stefania Crucitta, Giulia Gianfilippo, Antonio Passaro, Iacopo Petrini, Giuliana Restante, Angela Michelucci, Stefano Fogli, Filippo de Marinis, Camillo Porta, Antonio Chella, Romano Danesi
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy. International journal of molecular sciences 20 (16) (2019)
Valentina Citi, Marzia Del Re, Alma Martelli, Vincenzo Calderone, Maria Cristina Breschi, Romano Danesi
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro. Cancer chemotherapy and pharmacology 81 (4) (2018)
Antonio Cuneo, Giovanni Barosi, Romano Danesi, Stefano Fagiuoli, Paolo Ghia, Alfredo Marzano, Marco Montillo, Venerino Poletti, Pierluigi Viale, Pier Luigi Luigi Zinzani
Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper. Hematological oncology 37 (1) (2018)
Stefano Fogli, Marzia Del Re, Eleonora Rofi, Chiara Posarelli, Michele Figus, Romano Danesi
Clinical pharmacology of intravitreal anti-VEGF drugs. Eye (London, England) 32 (6) (2018)
Marzia Del Re, Elena Arrigoni, Giuliana Restante, Antonio Passaro, Eleonora Rofi, Stefania Crucitta, Filippo De Marinis, Antonello Di Paolo, Romano Danesi
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells. Stem cells (Dayton, Ohio) 36 (5) (2018)

Romano Danesi.css-eqlu8i{font-size:small;padding-left:4px;} (R Danesi)

Publication Activity (10 Years)

Top Topics

Top Venues

Romano Danesi (R Danesi)